Evidence map›Paper›PMID 38970018›Full record

ArticleJournal of translational medicine2024

Interplay between WNT/PI3K-mTOR axis and the microbiota in APC-driven colorectal carcinogenesis: data from a pilot study and possible implications for CRC prevention.

Floriana Jessica Di Paola, Chiara Alquati, Gabriele Conti, Giulia Calafato, Silvia Turroni, Federica D'Amico, Claudio Ceccarelli, Francesco Buttitta, Alice Bernardi, Dajana Cuicchi and 7 more

Abstract read
In one paragraph

Article in Journal of translational medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Gut Microbial Metabolism in Colorectal Cancer.Methods in molecular biology (Clifton, N.J.) · 2026
    Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Floriana Jessica Di Paola *IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy. floriana.dipaola2@unibo.it.
Chiara Alquati *Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
Gabriele Conti *Department of Pharmacy and Biotechnology, University of Bologna, Bologna, Italy.
Giulia CalafatoIRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
Silvia TurroniDepartment of Pharmacy and Biotechnology, University of Bologna, Bologna, Italy.
Federica D'AmicoDepartment of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
Claudio CeccarelliDepartment of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
Francesco ButtittaIRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
Alice BernardiDepartment of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
Dajana CuicchiIRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
Gilberto PoggioliIRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
Daniela TurchettiIRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
Simona FerrariIRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
Renato CannizzaroOncological Gastroenterology, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy.
Stefano RealdonOncological Gastroenterology, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy.
Patrizia BrigidiDepartment of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
Luigi RicciardielloIRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy. lricciardiello@mdanderson.org.ORCID 0000-0003-2568-6208

Funding

Associazione Italiana per la Ricerca sul Cancro 21723IR - BBMRI - CUP: B53C22001820006 IR - BBMRI - CUP: B53C22001820006Ministero della Salute Ministero della Salute
6 · The paper itself

Abstract

backgroundWnt/β-catenin signalling impairment accounts for 85% of colorectal cancers (CRCs), including sporadic and familial adenomatous polyposis (FAP) settings. An altered PI3K/mTOR pathway and gut microbiota also contribute to CRC carcinogenesis. We studied the interplay between the two pathways and the microbiota composition within each step of CRC carcinogenesis.

methodsProteins and target genes of both pathways were analysed by RT-qPCR and IHC in tissues from healthy faecal immunochemical test positive (FIT+, n = 17), FAP (n = 17) and CRC (n = 15) subjects. CRC-related mutations were analysed through NGS and Sanger. Oral, faecal and mucosal microbiota was profiled by 16 S rRNA-sequencing.

resultsWe found simultaneous hyperactivation of Wnt/β-catenin and PI3K/mTOR pathways in FAP-lesions compared to CRCs. Wnt/β-catenin molecular markers positively correlated with Clostridium_sensu_stricto_1 and negatively with Bacteroides in FAP faecal microbiota. Alistipes, Lachnospiraceae, and Ruminococcaceae were enriched in FAP stools and adenomas, the latter also showing an overabundance of Lachnoclostridium, which positively correlated with cMYC. In impaired-mTOR-mutated CRC tissues, p-S6R correlated with Fusobacterium and Dialister, the latter also confirmed in the faecal-ecosystem.

conclusionsOur study reveals an interplay between Wnt/β-catenin and PI3K/mTOR, whose derangement correlates with specific microbiota signatures in FAP and CRC patients, and identifies new potential biomarkers and targets to improve CRC prevention, early adenoma detection and treatment.

Indexed as

CarcinogenesisColorectal NeoplasmsPhosphatidylinositol 3-KinasesTOR Serine-Threonine KinasesWnt Signaling PathwayAdenomatous Polyposis ColiAdenomatous Polyposis Coli ProteinAdultAgedFecesFemaleGastrointestinal MicrobiomeHumansMaleMicrobiotaMiddle AgedAdenomatous Polyposis Coli ProteinAPC protein, humanPhosphatidylinositol 3-KinasesTOR Serine-Threonine KinasesColorectal cancerFamilial adenomatous polyposisMicrobiotaPI3K/mTORWnt/β-catenin

Identifiers

PMID38970018
PMCPMC11227240

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.